Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial DNA and DNA-associated enzymes represent a broad class of therapeutic targets essential for bacterial survival, growth, and reproduction (Molecular Biology of the Cell, 2002). This category includes the bacterial chromosome itself and the specialized enzymes required to maintain its topology and facilitate replication, such as DNA gyrase (Topoisomerase II) and Topoisomerase IV (StatPearls, 2023). These enzymes are distinct from human topoisomerases in structure and mechanism, allowing for selective toxicity in the treatment of bacterial infections (PubMed, PMC4933436). Antimicrobial agents targeting this system work through various mechanisms: fluoroquinolones stabilize enzyme-DNA complexes to induce lethal double-strand breaks, while nitroimidazoles like metronidazole are reduced to reactive intermediates that directly damage the DNA structure (PubChem, 2024). These targets are fundamental in treating a vast array of infectious diseases, ranging from simple urinary tract infections to life-threatening sepsis and tuberculosis, though the emergence of multi-drug resistant strains remains a significant clinical challenge (WHO, 2023).
Inhibition of DNA gyrase and topoisomerase IV to prevent DNA untangling and replication; direct induction of DNA strand breaks through reactive metabolites; inhibition of DNA-dependent RNA polymerase to block transcription.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial DNA and DNA-associated enzymes.